Tenaya Therapeutics Inc TNYA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
4.50UNCH (UNCH)
Volume
975
Close
4.50quote price arrow down-0.38 (-7.79%)
Volume
93,245
52 week range
4.41 - 32.00
Loading...
  • Open4.79
  • Day High4.87
  • Day Low4.45
  • Prev Close4.88
  • 52 Week High32.00
  • 52 Week High Date11/08/21
  • 52 Week Low4.41
  • 52 Week Low Date08/02/22

Key Stats

  • Market Cap186.12M
  • Shares Out41.36M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-76.25

KEY STATS

  • Open4.79
  • Day High4.87
  • Day Low4.45
  • Prev Close4.88
  • 52 Week High32.00
  • 52 Week High Date11/08/21
  • 52 Week Low4.41
  • 52 Week Low Date08/02/22
  • Market Cap186.12M
  • Shares Out41.36M
  • 10 Day Average Volume0.32M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-76.25

RATIOS/PROFITABILITY

  • EPS (TTM)-2.75
  • P/E (TTM)-1.64
  • Fwd P/E (NTM)-1.70
  • EBITDA (TTM)-100.40M
  • ROE (TTM)-180.12%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tenaya Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Tenaya Therapeutics, Inc. is a preclinical stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing a pipeline of disease-modifying therapies developed using its product platforms and capabilities to target defined sub-populations of patients with rare or other prevalent forms of heart disease. The Company is advancing product candidates from three...
David Goeddel Ph.D.
Independent Chairman of the Board
Faraz Ali
Chief Executive Officer, Director
Leone Patterson CPA
Chief Financial and Business Officer
Address
171 Oyster Point Blvd., Suite 500
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
GRPH
Graphite Bio Inc
3.57-0.25-6.54%
GRCL
Gracell Biotechnologies Inc
3.38+0.02+0.60%
ANNX
Annexon Inc
5.48-0.17-3.01%
CMRX
Chimerix Inc
2.43-0.10-3.95%
OMGA
Omega Therapeutics Inc
4.48-0.41-8.38%